These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8123656)

  • 21. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.
    Harris GM; Stendt CL; Vollenhoven BJ; Gan TE; Tipping PG
    Am J Hematol; 1999 Mar; 60(3):175-80. PubMed ID: 10072106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is tissue factor pathway inhibitor involved in the antithrombotic effect of heparins? Biochemical considerations.
    Ostergaard P; Nordfang O; Petersen LC; Valentin S; Kristensen H
    Haemostasis; 1993 Mar; 23 Suppl 1():107-11. PubMed ID: 8388348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of density distribution of plasma lipoproteins of normo- and hypercholesterolemic rhesus monkeys and humans.
    Fless GM; Scanu AM
    Arteriosclerosis; 1986; 6(1):88-97. PubMed ID: 3942563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody recognized the third Kunitz domain (K3) of free-form TFPI but not lipoprotein-associated forms in plasma.
    Abumiya T; Enjyoji K; Kokawa T; Kamikubo Y; Kato H
    J Biochem; 1995 Jul; 118(1):178-82. PubMed ID: 8537308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation.
    Yamamuro M; Wada H; Kumeda K; Inoue A; Tsuji I; Nakasaki T; Shimura M; Hiyoyama K; Gabazza EC; Nishikawa M; Deguchi K; Shiku H; Kato H
    Blood Coagul Fibrinolysis; 1998 Sep; 9(6):491-7. PubMed ID: 9818999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages : relationship to tissue factor induction by cholesterol and oxidized LDL.
    Petit L; Lesnik P; Dachet C; Moreau M; Chapman MJ
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):309-15. PubMed ID: 9974412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of dietary proteins on hepatic and plasma lipids, and some properties of major plasma lipoprotein fractions during dietary-induced hypercholesterolemia in male rats.
    Eklund A; Sjöblom L
    Biochim Biophys Acta; 1986 Jun; 877(1):127-34. PubMed ID: 3718994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathy.
    Yokoyama H; Myrup B; Rossing P; Ostergaard PB
    Diabetes Care; 1996 May; 19(5):441-5. PubMed ID: 8732706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on stroke-prone spontaneously hypertensive rats (SHRSP) fed a high-fat and high-cholesterol diet--effect of taurine on serum lipoprotein metabolism in hypercholesterolemic rats].
    Ogawa H; Nishikawa T; Fukushima S; Sasagawa S
    Nihon Eiseigaku Zasshi; 1989 Jun; 44(2):648-58. PubMed ID: 2810865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
    Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
    Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of doxazosin, an alpha 1-adrenergic inhibitor, on plasma lipid and lipoprotein levels, low density lipoprotein metabolism and cholesterol absorption in cynomolgus monkeys.
    Stucchi AF; Vespa DB; Terpstra AH; Nicolosi RJ
    Atherosclerosis; 1993 Nov; 103(2):255-66. PubMed ID: 8292100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys.
    van Heek M; Compton DS; Davis HR
    Eur J Pharmacol; 2001 Mar; 415(1):79-84. PubMed ID: 11245855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue factor pathway inhibitor in complex with low density lipoprotein isolated from human plasma does not possess anticoagulant function in tissue factor-induced coagulation in vitro.
    Hansen JB; Huseby KR; Huseby NE; Ezban M; Nordøy A
    Thromb Res; 1997 Mar; 85(5):413-25. PubMed ID: 9076898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5 alpha-Cholest-8(14)-en-3 beta-ol-15-one lowers serum cholesterol and induces profound changes in the levels of lipoprotein cholesterol and apoproteins in monkeys fed a diet of moderate cholesterol content.
    Schroepfer GJ; Sherrill BC; Wang KS; Wilson WK; Kisic A; Clarkson TB
    Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6861-5. PubMed ID: 6593730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of prazosin on hemodynamics, hemostasis, and serum lipid and lipoprotein levels in normal and hypercholesterolemic monkeys.
    Karge WH; Weiner EJ; Kowala MC; Graham RM; Nicolosi RJ
    Am J Med; 1989 Jan; 86(1B):19-23. PubMed ID: 2913768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
    Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating levels of endothelial function are modulated by dietary monounsaturated fat.
    Pérez-Jiménez F; Castro P; López-Miranda J; Paz-Rojas E; Blanco A; López-Segura F; Velasco F; Marín C; Fuentes F; Ordovás JM
    Atherosclerosis; 1999 Aug; 145(2):351-8. PubMed ID: 10488963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of plasma lipoproteins of common marmoset monkey. Comparison of effects of control and atherogenic diets.
    Crook D; Weisgraber KH; Boyles JK; Mahley RW
    Arteriosclerosis; 1990; 10(4):633-47. PubMed ID: 2114868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of dietary casein and soy protein on cholesterol and very low density lipoprotein metabolism in the rat.
    Cohn JS; Kimpton WG; Nestel PJ
    Atherosclerosis; 1984 Aug; 52(2):219-31. PubMed ID: 6541048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].
    Saito M; Morishita E; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Yamazaki M; Aoshima K; Matsuda T
    Rinsho Ketsueki; 1996 Sep; 37(9):794-8. PubMed ID: 8914465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.